DNA Sequencing Facility (Laura R. Livingstone, Ph.D., Facility Director) The rapid acquisition of sequence information is central to progress in many areas of cancer research. The UNC-CH automated DNA Sequencing Facility, opened in 1992, consolidates the use of expensive technologies and provides Cancer Center investigators with access to state-of-the-art DNA sequencing resources. The facility generates high quality DNA sequences with consistently long read lengths (700-800 nucleotides) and provides: standard vector primers; information on sample preparation; help with sequence data interpretation; and assistance with large-project sequencing. The facility also collaborates with the UNC Center of BioInformatics to train investigators on analysis of DNA sequence data, and has developed Internet resources that allow users to edit their sequence data using personal computers and permit direct importing in the sequence analysis package, GCG. Use has increased dramatically over the last five years and capacity has doubled with the addition of two automated DNA sequencers upgraded to run 80 lanes per ge1 run. Approximately 60% of LCCC members from virtually every program have used the facility. Use increased last year to over 20,000 sequences (58% for LCCC members) in part because LCCC contributions have enabled a price reduction for members from $28 to $15 per standard run in the space of 24 months. With the proposed CCSG contribution of $96,118 (17% of total budget), the facility will maintain the lower prices that have led to growing use by LCCC members. The CCSG funds will primarily support the facility's technician (100%) and Director (60%).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-25
Application #
6404880
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1981-08-01
Project End
2004-11-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Bigi, Rachele; Landis, Justin T; An, Hyowon et al. (2018) Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 115:E11379-E11387
Liu, Jianfang; Lichtenberg, Tara; Hoadley, Katherine A et al. (2018) An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173:400-416.e11
Song, Lixin; Dunlap, Kaitlyn L; Tan, Xianming et al. (2018) Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using a Couple-Focused mHealth Symptom Self-Management Program: Protocol for a Feasibility Study. JMIR Res Protoc 7:e51
Guseman, Alex J; Perez Goncalves, Gerardo M; Speer, Shannon L et al. (2018) Protein shape modulates crowding effects. Proc Natl Acad Sci U S A 115:10965-10970
Xu, Bowen; Cai, Ling; Butler, Jason M et al. (2018) The Chromatin Remodeler BPTF Activates a Stemness Gene-Expression Program Essential for the Maintenance of Adult Hematopoietic Stem Cells. Stem Cell Reports 10:675-683
Gartlan, Kate H; Bommiasamy, Hemamalini; Paz, Katelyn et al. (2018) A critical role for donor-derived IL-22 in cutaneous chronic GVHD. Am J Transplant 18:810-820
Zhang, Yugen; Dittmer, Dirk P; Mieczkowski, Piotr A et al. (2018) RIG-I Detects Kaposi's Sarcoma-Associated Herpesvirus Transcripts in a RNA Polymerase III-Independent Manner. MBio 9:
Abida, Wassim; Sawyers, Charles L (2018) Targeting DNA Repair in Prostate Cancer. J Clin Oncol 36:1017-1019
Horner, Marie-Josèphe; Salima, Ande; Chilima, Chrissie et al. (2018) Frequent HIV and Young Age Among Individuals With Diverse Cancers at a National Teaching Hospital in Malawi. J Glob Oncol :1-11
Gilkey, Melissa B; Zhou, Mo; McRee, Annie-Laurie et al. (2018) Parents' Views on the Best and Worst Reasons for Guideline-Consistent HPV Vaccination. Cancer Epidemiol Biomarkers Prev 27:762-767

Showing the most recent 10 out of 1525 publications